Russia's Gamaleya Centre Applies for Registration of Nasal Vaccine Against COVID-19

© Photo : THE RUSSIAN DIRECT INVESTMENT FUA scientist works inside a laboratory of the Gamaleya Research Institute of Epidemiology and Microbiology during the production and laboratory testing of a vaccine against the coronavirus disease (COVID-19), in Moscow, Russia August 6, 2020
A scientist works inside a laboratory of the Gamaleya Research Institute of Epidemiology and Microbiology during the production and laboratory testing of a vaccine against the coronavirus disease (COVID-19), in Moscow, Russia August 6, 2020 - Sputnik International, 1920, 18.03.2022
Subscribe
MOSCOW (Sputnik) - Russia's Gamaleya National Research Centre for Epidemiology and Microbiology has filed documents for the registration of a nasal version of its Sputnik V vaccine against COVID-19, the Russian Health Ministry said on Friday.
"Date of registration of the incoming number: 03.18.2022. Trade name: Gam-COVID-Vac Combined vector vaccine for the prevention of the coronavirus infection caused by the SARS-CoV-2 virus", a report said.
The original Sputnik V (Gam-COVID-Vac) was registered in August 2020. The two-dose vaccine has a single-dose version, Sputnik Light, and a version for teenagers, Sputnik M. Russia also produces three other COVID-19 vaccines including CoviVac, EpiVacCorona, and EpiVacCorona N.
Let's stay in touch no matter what! Follow our Telegram channel to get all the latest news: https://t.me/sputniknewsus
Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала